Typicality: | 0.345 |
Saliency: | 0.223 |
at the second planned interim analysis | 2 | temporal |
trial → be stopped for → efficacy | 12 |
negative | neutral | positive |
0.259 | 0.644 | 0.097 |
Raw frequency | 12 |
Normalized frequency | 0.223 |
Modifier score | 0.500 |
Perplexity | 336.191 |